SCN2A and Intellectual disability: By analyzing data from 695 patients across 11 studies, the findings highlight the prevalence of SCN2A mutations in ASD and their significant contribution to diverse neurological symptoms, including seizures, intellectual disability, motor impairments, and behavioral deficits.